These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17955826)

  • 21. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macroalbuminuria and microalbuminuria: do both predict renal and cardiovascular events with similar strength?
    de Jong PE; Gansevoort RT; Bakker SJ
    J Nephrol; 2007; 20(4):375-80. PubMed ID: 17879201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of microalbuminuria in the overall risk assessment of hypertensive patients].
    Leoncini G; Ratto E; Viazzi F; Pontremoli R
    G Ital Nefrol; 2007; 24(6):565-73. PubMed ID: 18278760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Higher brachial-ankle pulse wave velocity as an independent risk factor for future microalbuminuria in patients with essential hypertension: the J-TOPP study.
    Munakata M; Miura Y; Yoshinaga K;
    J Hypertens; 2009 Jul; 27(7):1466-71. PubMed ID: 19412131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulse pressure or dipping pattern: which one is a better cardiovascular risk marker in resistant hypertension?
    Muxfeldt ES; Salles GF
    J Hypertens; 2008 May; 26(5):878-84. PubMed ID: 18398329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of association between TGF-beta-1 genotypes and microalbuminuria in essential hypertensive men.
    Dell'Omo G; Penno G; Pucci L; Lucchesi D; Del Prato S; Pedrinelli R
    Nephrol Dial Transplant; 2009 Jun; 24(6):1864-9. PubMed ID: 19176688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chronic renal insufficiency and cardiovascular disease].
    Charriere S; Rognant N; Chiche F; Cremer A; Deray G; Priou M
    Ann Cardiol Angeiol (Paris); 2009 Feb; 58(1):40-52. PubMed ID: 18937921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic syndrome and target organ damage: role of blood pressure.
    Cuspidi C; Sala C; Zanchetti A
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):731-43. PubMed ID: 18510489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving cardiovascular risk stratification: the case for redefining microalbuminuria.
    Leoncini G; Ratto E; Viazzi F; Parodi A; Falqui V; Conti N; Tomolillo C; Deferrari G; Pontremoli R
    J Nephrol; 2007; 20 Suppl 12():S51-5. PubMed ID: 18050144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension.
    Ratto E; Leoncini G; Viazzi F; Bezante GP; Falqui V; Parodi A; Conti N; Tomolillo C; Deferrari G; Pontremoli R
    J Hypertens; 2008 Feb; 26(2):345-50. PubMed ID: 18192849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.
    Palmer AJ; Valentine WJ; Chen R; Mehin N; Gabriel S; Bregman B; Rodby RA
    Nephrol Dial Transplant; 2008 Apr; 23(4):1216-23. PubMed ID: 18359872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Proven and new parameters of hypertensive target organ damage].
    Schmidt BM; Schmieder RE
    Dtsch Med Wochenschr; 2006 Nov; 131(46 Spec No):H20-3. PubMed ID: 17109244
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hypertension and renal disease].
    Kamper AL; Pedersen EB; Strandgaard S
    Ugeskr Laeger; 2009 Jun; 171(25):2109-13. PubMed ID: 19671393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Microalbuminuria].
    Olsen MH; Ibsen H; Mogensen CE
    Ugeskr Laeger; 2009 Jun; 171(25):2097-100. PubMed ID: 19671389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice.
    Barrios V; Escobar C; Murga N; de Pablo C; Bertomeu V; Calderón A; Echarri R
    J Hypertens; 2008 Nov; 26(11):2230-5. PubMed ID: 18854765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteinuria in children with sickle cell disease.
    Marsenic O; Couloures KG; Wiley JM
    Nephrol Dial Transplant; 2008 Feb; 23(2):715-20. PubMed ID: 18065783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review article: Early detection of chronic kidney disease in Australia: which way to go?
    Mathew T; Corso O
    Nephrology (Carlton); 2009 Jun; 14(4):367-73. PubMed ID: 19563377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.